J&J to Take Stake in Elan
J&J agreed to buy an 18.4% stake in Elan for $1 billion and acquire the rights to much of the biotech's Alzheimer's research.
Comment on "J&J to Take Stake in Elan"
| Related News: |
| Tools for Agents at Real Estate Pro Resource | |||||
|
|||||